20075-26-7

Basic information

• Product Name: 1-(methoxymethyl)-1H-imidazole
• Synonyms: 1-(methoxymethyl)-1H-imidazole;1-(Methoxymethyl)imidazole;Einecs 243-505-3;1-(Methoxymethyl)
• CAS NO: 20075-26-7
• Molecular Formula: C₅H₈N₂O
• Molecular Weight: 112.12982
• EINECS: 243-505-3
• Mol File: 20075-26-7.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 227.2°Cat760mmHg
• Flash Point: 91.2°C
• Appearance: /
• Density: 1.06g/cm³
• Vapor Pressure: 0.118mmHg at 25°C
• Refractive Index: 1.505
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 6.53±0.10(Predicted)
• CAS DataBase Reference: 1-(methoxymethyl)-1H-imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(methoxymethyl)-1H-imidazole(20075-26-7)
• EPA Substance Registry System: 1-(methoxymethyl)-1H-imidazole(20075-26-7)

Safety Data

• Hazardous Substances Data: 20075-26-7(Hazardous Substances Data)

Usage

General Description

1-(Methoxymethyl)-1H-imidazole is a specific type of organic chemical compound, known for its imidazole ring structure with a methoxymethyl group attached to its nitrogen atom. 1-(methoxymethyl)-1H-imidazole belongs to the family of imidazoles, known for their versatile biological activity and importance in certain medications. A variety of chemicals have been synthesized from it and are gaining importance in medicinal chemistry due to their antifungal, antibacterial, and antiprotozoal activities. Additionally, imidazoles are found in many natural and non-natural compounds, demonstrating their significance in both biological and synthetic chemistry. Because of their versatility and productivity, they are used as starting materials in the synthesis of a large number of heterocyclic compounds.

InChI:InChI=1/C5H8N2O/c1-8-5-7-3-2-6-4-7/h2-4H,5H2,1H3

Upstream product

• 288-32-4 1H-imidazole 
• 107-30-2 chloromethyl methyl ether 
• 93342-84-8 1-(p-methoxybenzoyl)-3-methoxymethylimidazolium chloride 

Downstream Products

• 93342-84-8 1-(p-methoxybenzoyl)-3-methoxymethylimidazolium chloride 
• 160425-46-7 3-Methoxymethyl-3H-imidazole-4-carbaldehyde 
• 49822-73-3 bis-(4-fluoro-phenyl)-(1-methoxymethyl-1H-imidazol-2-yl)-methanol 
• 49822-61-9 bis-(4-chloro-phenyl)-(1-methoxymethyl-1H-imidazol-2-yl)-methanol 
• 49822-92-6 (2-tert-butyl-phenyl)-(1-methoxymethyl-1H-imidazol-2-yl)-phenyl-methanol 
• 49823-01-0 (2,4-dichloro-phenyl)-(4-fluoro-phenyl)-(1-methoxymethyl-1H-imidazol-2-yl)-methanol 
• 49822-99-3 (4-tert-butyl-phenyl)-(4-chloro-phenyl)-(1-methoxymethyl-1H-imidazol-2-yl)-methanol 
• 1007596-37-3 1-[1-(methoxymethyl)-1H-imidazol-2-yl]ethanone 
• 1333378-11-2 C₄₁H₃₅BrN₈O₆S₂ 
• 1333378-12-3 C₃₁H₃₁N₇O₄S₂ 
• 1333378-30-5 C₃₆H₃₉N₇O₆S₂ 
• 1333378-21-4 C₂₉H₂₇N₃O₄S₂ 
• 1094172-58-3 C₁₁H₁₃BN₂O₃S 
• 1094172-73-2 C₄₃H₄₆N₄O₉S₃ 

Relevant articles and documents

Assembly of the active center of organophosphorus hydrolase in metal-organic frameworks: Via rational combination of functional ligands

Different from popular mimics of bimetallic nuclear centers bridged by a hydroxide, a total coordination sphere of the active center of organophosphorus hydrolase was assembled in metal-organic frameworks by rational design and combination of ligands, which resulted in efficient destruction of nerve agent stimulants without a base as a co-catalyst.

BIOACTIVE COMPOUNDS FOR TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES

The invention provides bioactive compounds for the treatment of various malconditions such as cancer and neurodegenerative diseases including Alzheimer's disease. The chemical compounds as disclosed herein are found to show bioactivity in bioassays related to these conditions. Pharmaceutical compositions, combinations and methods of synthesis are provided, as are methods of using the compound, compositions and combinations in the treatment of the diseases.

Arylsulfonamidobenzylic compounds

Arylsulfonamidobenzyl alcohols, amines and sulfonamides are provided which are useful in treating lipid disorders, metabolic diseases and cell-proliferative diseases.